Skip to content
Alzheimer's Association. "Driving," 2007. Available at www.alz.org.
Duchek JM, et al. "Longitudinal Driving Performance in
Early-Stage Dementia of the Alzheimer Type," Journal of the
American Geriatric Society (Oct. 2003): Vol. 51, No. 10, pp.
Erten-Lyons D. "When Should Patients with Alzheimer Disease Stop
Driving?" Neurology (April 1, 2008): Vol. 70, No. 14, pp. e45–47.
Fava M, et al. "A Comparison of Mirtazapine and Nortriptyline
Following Two Consecutive Failed Medication Treatments for
Depressed Outpatients: A STAR*D Report," American Journal of
Psychiatry (July 2006): Vol. 163, No. 7, pp. 1161–72.
Gaynes BN, et al. "The STAR*D Study: Treating Depression in the
Real World," Cleveland Clinic Journal of Medicine (Jan. 2008):
Vol. 75, No. 1, pp. 57–66.
McGrath PJ, et al. "Tranylcypromine Versus Venlafaxine Plus
Mirtazapine Following Three Failed Medication Trials for
Depression: A STAR*D Report," American Journal of Psychiatry
(Sept. 2006): Vol. 163, No. 9, pp. 1531–41.
American Psychiatric Association. "Mandatory Outpatient Treatment
Resource Document," December 1999. APA Document Reference No.
Angell B, et al. "Payeeship, Financial Leverage, and the
Client-Provider Relationship," Psychiatric Services (March 2007):
Vol. 58, No. 3, pp. 365–72.
Appelbaum PS, et al. "Use of Leverage Over Patients' Money to
Promote Adherence to Psychiatric Treatment," Journal of Nervous
and Mental Disorders (April 2006): Vol. 194, No. 4, pp. 294–302.
Most people with depression will have to try more than one
medication before seeing positive results. Research shows that a
medication should be taken for at least eight weeks before adding
a second drug or trying a different one.
Involuntary outpatient commitment laws exist in most states, but
enforcement varies. Two studies on the issue produced contrasting
The onset of dementia can increase the risks of driving for older
people. Older drivers, their family members, and doctors should
be alert for patterns of behavior that indicate diminished
capacity behind the wheel.
A drug trial found that people with a family history of
Alzheimer's disease did not benefit from taking an NSAID. In
fact, testing showed that the subjects who took one of these
drugs scored lower on tests of cognitive function.
Researchers believe that bipolar disorder is being overdiagnosed,
perhaps because clinicians find it easier to treat than disorders
with similar symptoms, such as depression.
Young children with obsessive-compulsive disorder may benefit
from family-based cognitive behavioral therapy.
What is Munchhausen's syndrome by proxy and why is it not in the